Involvement of Myc targets in c-myc and N-myc induced human tumors

T Ben-Yosef1, O Yanuka, D Halle

  • 1Department of Genetics, Institute of Life Sciences, The Hebrew University of Jerusalem, Givat-Ram, Israel.

Oncogene
|July 23, 1998
PubMed

Insights

Myc proto-oncogenes regulate gene expression, impacting human oncogenesis. This study shows Myc target genes are involved in breast cancer and lymphomas, with complex regulation in neuronal cancers.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Background:

  • Myc proto-oncogenes are transcription factors binding to CACGTG DNA sequences.
  • Key c-Myc target genes include ECA39, p53, ornithine decarboxylase (ODC), alpha-prothymosin, and Cdc25A.
  • Myc gene family members (c-Myc, N-Myc) are implicated in various human cancers.

Purpose of the Study:

  • To investigate the role of c-Myc target genes in human oncogenesis driven by c-myc or N-myc.
  • To determine if Myc target gene expression correlates with Myc overexpression in different cancer types.

Main Methods:

  • Analysis of c-Myc and its target gene expression in MCF-7 breast cancer cells after estrogen induction.
  • Examination of Myc target gene expression in human breast tumors with c-myc overexpression.
  • Correlation analysis of c-myc and target gene expression in Burkitt's lymphomas and other lymphoma cells.
  • Investigation of Myc target gene expression patterns in neuroepithelioma and neuroblastoma cell lines.

Main Results:

  • Estrogen-induced c-myc expression in MCF-7 cells led to the induction of all examined Myc targets.
  • Overexpression of c-myc in breast tumors correlated with the overexpression of several Myc target genes.
  • A strong correlation between c-myc and its targets was observed in Burkitt's lymphomas but not other lymphomas.
  • Neuronal-derived cells showed complex Myc target gene expression patterns; N-Myc overexpression in neuroblastomas primarily correlated with ODC overexpression.

Conclusions:

  • Myc target genes play a role in human oncogenesis, particularly in breast cancer and specific lymphomas.
  • Regulation of Myc target genes by N-Myc in neuronal cancers is suggested but appears to require additional cell-specific factors.
  • The study highlights differential regulation of Myc targets depending on the Myc family member and cellular context.

Related Concept Videos

Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...